Seventure and LSP invest €4.4m in Mint

LSP and Seventure co-led the round, which saw Mint's existing investors participate. The company has previously received funding from Icelandic firm NSA Ventures and accelerator Startupbootcamp.

Until now, the company has been based in Kópavogur, Iceland, but has relocated its headquarters to Amsterdam in conjunction with the fresh capital injection. Its MedEye product has already been deployed in the Netherlands, as well as in Germany and the UK.

Previous funding
NSA invested in Mint in April 2011.

Company
Mint has developed MedEye, a combination of software and hardware designed to prevent medication errors in hospitals.

The company has devised a hardware unit that dispenses medication; the premise of the product is to decrease medication errors. MedEye is designed to allow hospitals and nurses to ensure that the various types of medication, such as tablets or syringes, are administered to the right patient at the correct time.

Mint was founded in 2010 and employs 11 staff.

People
Gauti Reynisson is the CEO of Mint; he founded the company alongside Ívar Helgason. Anne Portwich is a partner at LSP, while Eric de la Fortelle is a partner at Seventure. Both will join the company's board of directors.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Expansion
• Healthcare
• Netherlands
• Iceland
• Seventure (SPEF)
• Life Science Partners